194 related articles for article (PubMed ID: 26155314)
1. DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition.
Wu X; Zhao Z; Bai H; Fu T; Yang C; Hu X; Liu Q; Champanhac C; Teng IT; Ye M; Tan W
Theranostics; 2015; 5(9):985-94. PubMed ID: 26155314
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-SH2 superbinder-based targeted therapy for pancreatic ductal adenocarcinoma.
Liu AD; Zhou J; Bi XY; Hou GQ; Li SS; Chen Q; Xu H; Cao X
Clin Transl Med; 2021 Mar; 11(3):e337. PubMed ID: 33783993
[TBL] [Abstract][Full Text] [Related]
3. Antitumor Activity of Lipid-DNA Aptamer Modified T Lymphocytes in Carcinoma.
Zhong L; Gan L; Deng Z; Liu X; Peng H; Tang H; Liu X; Fang F; Yao F; Li W; Liu Z; Hou W; Cui C; Zhao Y; Tan W; Shi W; He J
J Biomed Nanotechnol; 2020 Jul; 16(7):1110-1118. PubMed ID: 33308378
[TBL] [Abstract][Full Text] [Related]
4. A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma.
Clawson GA; Abraham T; Pan W; Tang X; Linton SS; McGovern CO; Loc WS; Smith JP; Butler PJ; Kester M; Adair JH; Matters GL
Nucleic Acid Ther; 2017 Feb; 27(1):23-35. PubMed ID: 27754762
[TBL] [Abstract][Full Text] [Related]
5. Development of a panel of DNA Aptamers with High Affinity for Pancreatic Ductal Adenocarcinoma.
Champanhac C; Teng IT; Cansiz S; Zhang L; Wu X; Zhoa Z; Fu T; Tan W
Sci Rep; 2015 Nov; 5():16788. PubMed ID: 26603187
[TBL] [Abstract][Full Text] [Related]
6. An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer.
Liu M; Wang Z; Tan T; Chen Z; Mou X; Yu X; Deng Y; Lu G; He N
Theranostics; 2018; 8(20):5772-5783. PubMed ID: 30555580
[TBL] [Abstract][Full Text] [Related]
7. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells.
Zhao Z; Xu L; Shi X; Tan W; Fang X; Shangguan D
Analyst; 2009 Sep; 134(9):1808-14. PubMed ID: 19684903
[TBL] [Abstract][Full Text] [Related]
8. Metastatic cancer cell and tissue-specific fluorescence imaging using a new DNA aptamer developed by Cell-SELEX.
Yuan B; Jiang X; Chen Y; Guo Q; Wang K; Meng X; Huang Z; Wen X
Talanta; 2017 Aug; 170():56-62. PubMed ID: 28501211
[TBL] [Abstract][Full Text] [Related]
9. Selection and characterization of DNA aptamer for metastatic prostate cancer recognition and tissue imaging.
Duan M; Long Y; Yang C; Wu X; Sun Y; Li J; Hu X; Lin W; Han D; Zhao Y; Liu J; Ye M; Tan W
Oncotarget; 2016 Jun; 7(24):36436-36446. PubMed ID: 27183906
[TBL] [Abstract][Full Text] [Related]
10. A two-step stimulus-response cell-SELEX method to generate a DNA aptamer to recognize inflamed human aortic endothelial cells as a potential in vivo molecular probe for atherosclerosis plaque detection.
Ji K; Lim WS; Li SF; Bhakoo K
Anal Bioanal Chem; 2013 Aug; 405(21):6853-61. PubMed ID: 23842900
[TBL] [Abstract][Full Text] [Related]
11. Evolution of DNA aptamers for malignant brain tumor gliosarcoma cell recognition and clinical tissue imaging.
Wu Q; Wu L; Wang Y; Zhu Z; Song Y; Tan Y; Wang XF; Li J; Kang D; Yang CJ
Biosens Bioelectron; 2016 Jun; 80():1-8. PubMed ID: 26802746
[TBL] [Abstract][Full Text] [Related]
12. FRY site-specific methylation differentiates pancreatic ductal adenocarcinoma from other adenocarcinomas.
Srisuttee R; Ota J; Muangsub T; Keelawat S; Trirattanachat S; Kitkumthorn N; Mutirangura A
APMIS; 2016 Jun; 124(6):469-74. PubMed ID: 26990916
[TBL] [Abstract][Full Text] [Related]
13. Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles.
Wang FB; Rong Y; Fang M; Yuan JP; Peng CW; Liu SP; Li Y
Biomaterials; 2013 May; 34(15):3816-27. PubMed ID: 23465488
[TBL] [Abstract][Full Text] [Related]
14. Elucidation and Structural Modeling of CD71 as a Molecular Target for Cell-Specific Aptamer Binding.
Wu X; Liu H; Han D; Peng B; Zhang H; Zhang L; Li J; Liu J; Cui C; Fang S; Li M; Ye M; Tan W
J Am Chem Soc; 2019 Jul; 141(27):10760-10769. PubMed ID: 31185171
[TBL] [Abstract][Full Text] [Related]
15. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
16. Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX.
Li S; Xu H; Ding H; Huang Y; Cao X; Yang G; Li J; Xie Z; Meng Y; Li X; Zhao Q; Shen B; Shao N
J Pathol; 2009 Jul; 218(3):327-36. PubMed ID: 19291713
[TBL] [Abstract][Full Text] [Related]
17. Selection and characterization of DNA aptamers against VEGF165 with aptamer blotting method and its application.
Ikebukuro K; Hasegawa H; Sode K
Nucleic Acids Symp Ser (Oxf); 2007; (51):399-400. PubMed ID: 18029755
[TBL] [Abstract][Full Text] [Related]
18. Selecting DNA aptamers for endotoxin separation.
Ying G; Zhu F; Yi Y; Chen J; Mei J; Zhang Y; Chen S
Biotechnol Lett; 2015 Aug; 37(8):1601-5. PubMed ID: 25896682
[TBL] [Abstract][Full Text] [Related]
19. X-aptamers targeting Thy-1 membrane glycoprotein in pancreatic ductal adenocarcinoma.
Wang H; Li X; Lai LA; Brentnall TA; Dawson DW; Kelly KA; Chen R; Pan S
Biochimie; 2021 Feb; 181():25-33. PubMed ID: 33242496
[TBL] [Abstract][Full Text] [Related]
20. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
